BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27929429)

  • 1. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.
    Armstrong SR; Wu H; Wang B; Abuetabh Y; Sergi C; Leng RP
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
    Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP
    Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TUMOR SUPPRESSOR p63 REGULATES EXPRESSION OF UBIQUITIN LIGASE Pirh2].
    Daks AA; Petukhov AV; Shuvalov OY; Vasilieva EA; Melino G; Barlev NA; Fedorova OA
    Tsitologiia; 2015; 57(12):876-9. PubMed ID: 26995965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itch/AIP4 associates with and promotes p63 protein degradation.
    Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V
    Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
    Corcoran CA; Huang Y; Sheikh MS
    Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.
    Fan C; Wang X
    Cell Cycle; 2017 Apr; 16(7):660-664. PubMed ID: 28166445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.
    Marcar L; Ihrig B; Hourihan J; Bray SE; Quinlan PR; Jordan LB; Thompson AM; Hupp TR; Meek DW
    PLoS One; 2015; 10(5):e0127713. PubMed ID: 26001071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity.
    Ranaweera RS; Yang X
    J Biol Chem; 2013 Jun; 288(26):18939-46. PubMed ID: 23671280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
    Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
    Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
    J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MdmX on Mdm2-mediated downregulation of pRB.
    Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M
    FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
    Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
    Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Discovery to Bedside: Targeting the Ubiquitin System.
    Wertz IE; Wang X
    Cell Chem Biol; 2019 Feb; 26(2):156-177. PubMed ID: 30554913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
    Brignone C; Bradley KE; Kisselev AF; Grossman SR
    Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting the power of p53 through the ubiquitin proteasome pathway.
    Pant V; Lozano G
    Genes Dev; 2014 Aug; 28(16):1739-51. PubMed ID: 25128494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoke induces Akt protein degradation by the ubiquitin-proteasome system.
    Kim SY; Lee JH; Huh JW; Ro JY; Oh YM; Lee SD; An S; Lee YS
    J Biol Chem; 2011 Sep; 286(37):31932-43. PubMed ID: 21778238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.